Company / Working Capital per Share
TherapeuticsMD, Inc. Working Capital per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.62
FY2024
5-year range
-$0.45 / $0.99
FY2020-FY2024
Trend
+18.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 10 years, ranging from $-0.45 in FY2021 to $0.99 in FY2022.
Based on SEC 10-K filings.
0.62 in FY2024 with a 5-year CAGR of -1.0%.
Declined from $0.99 to $0.62 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -1.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, working capital per share increased 18.2% year-over-year.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.62 | +18.2% |
| FY2023 | $0.52 | -47.4% |
| FY2022 | $0.99 | +322.4% |
| FY2021 | -$0.45 | -274.5% |
| FY2020 | $0.26 | -60.5% |
| FY2019 | $0.65 | -4.0% |
| FY2018 | $0.67 | +4.9% |
| FY2017 | $0.64 | -8.2% |
| FY2016 | $0.70 | +68.9% |
| FY2015 | $0.41 | +31.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026